Short Interest in Azitra, Inc. (NYSEAMERICAN:AZTR) Grows By 6,463.0%

Azitra, Inc. (NYSEAMERICAN:AZTR) was the recipient of a large increase in short interest in August. As of August 31st, there was short interest totaling 1,368,917 shares, an increase of 6,463.0% from the August 15th total of 20,858 shares. Approximately 2.3% of the shares of the company are short sold. Based on an average trading volume of 4,230,483 shares, the short-interest ratio is currently 0.3 days.

Azitra Trading Down 1.1%

Shares of AZTR stock opened at $0.18 on Friday. Azitra has a 12 month low of $0.10 and a 12 month high of $1.09. The stock has a 50 day moving average of $0.15 and a two-hundred day moving average of $0.19.

Azitra (NYSEAMERICAN:AZTR) last released its quarterly earnings data on Wednesday, August 12th. The company reported ($0.17) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.12) by ($0.05). On average, equities analysts anticipate that Azitra will post -0.25 earnings per share for the current fiscal year.

Azitra Company Profile

Azitra Inc is a clinical-stage biopharmaceutical company focused on developing live bacterial therapies for dermatological conditions. Headquartered in Cambridge, Massachusetts, the company leverages its proprietary ActoBiotic platform to formulate topical treatments that aim to modulate the skin’s native microbial ecosystem.

The company’s lead investigational therapies are being evaluated in early-phase clinical studies for inflammatory skin disorders, including atopic dermatitis and other conditions characterized by microbial imbalance.